Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 2352767)

Published in Pain on April 01, 1990

Authors

I Jurna1, K Brune

Author Affiliations

1: Institut für Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg/Saar, F.R.G.

Articles citing this

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A (2002) 4.80

The mechanisms of action of NSAIDs in analgesia. Drugs (1996) 1.14

Dose-related effects of ibuprofen on pain-related potentials. Br J Clin Pharmacol (1994) 0.96

Inhibition of acute inflammation in the periphery by central action of salicylates. Proc Natl Acad Sci U S A (1991) 0.89

Effects of systemic non-steroidal anti-inflammatory drugs on nociception during tail ischaemia and on reperfusion hyperalgesia in rats. Br J Pharmacol (1992) 0.84

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Int J Clin Pract (2007) 0.80

Effects of azapropazone on pain-related brain activity in human subjects. Br J Clin Pharmacol (1995) 0.79

NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data. Pharmaceuticals (Basel) (2010) 0.75

Central antinociceptive-analgesic effect of diclofenac. Pain (2002) 0.75

Potent anti-inflammatory/analgesic effects of lornoxicam in comparison to other nsaids: a c-fos study in the rat. Inflammopharmacology (1997) 0.75

[Neuropathic pain : How to open the blackbox]. Schmerz (2015) 0.75

Differential analgesic effects of aspirin-like drugs. Drugs (1992) 0.75

Articles by these authors

(truncated to the top 100)

Assessment of phagocytic and antimicrobial activity of human granulocytes. Infect Immun (1974) 1.96

Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93

The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93

Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83

Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch Toxicol (1990) 1.59

Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51

Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature (1978) 1.44

Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42

Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42

Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules. J Infect Dis (1973) 1.39

Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.36

Leukocytes and prostaglandins in acute inflammation. Experientia (1974) 1.35

Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30

Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28

Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24

Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci (1988) 1.17

Biodistribution of mild analgesics. Br J Clin Pharmacol (1980) 1.12

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12

Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11

Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10

Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10

Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth (1993) 1.10

Prostaglandin release from macrophages: an assay system for anti-inflammatory drugs in vitro. Agents Actions (1977) 1.08

Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08

Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. Agents Actions Suppl (1986) 1.07

Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions (1990) 1.06

Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol (1994) 1.05

Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs (1991) 1.04

Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02

Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01

Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01

Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol (1998) 1.00

Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun (2000) 0.99

Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci (2000) 0.99

Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins (1991) 0.99

Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain (1995) 0.98

Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions (1983) 0.98

How aspirin might work: a pharmacokinetic approach. Agents Actions (1974) 0.97

Role of the parietal cell in gastric damage induced by aspirin and related drugs: implications for safer therapy. Med J Aust (1976) 0.97

Non-steroid anti-inflammatory drugs: influence of extra-cellular pH on biodistribution and pharmacological effects. Biochem Pharmacol (1978) 0.95

[Treatment of tension-type headache. Recommendation of the German Migraine and Headache Society]. Schmerz (1998) 0.95

Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol (1989) 0.95

Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. Eur J Clin Pharmacol (1990) 0.94

Ibuprofen as an over-the-counter drug: is there a risk for renal injury? Clin Nephrol (1993) 0.94

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration. Clin Pharmacol Ther (1999) 0.94

High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids. J Chromatogr (1989) 0.94

Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci (2001) 0.93

Stereoselective high-performance liquid chromatographic determination of flurbiprofen in human plasma. J Chromatogr (1992) 0.93

Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther (2004) 0.93

Mechanisms of action of anti-inflammatory drugs. Gen Pharmacol (1976) 0.93

Identification and characterization of inhibitors of peptido-leukotriene-synthesis from Petasites hybridus. Planta Med (1994) 0.92

Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. Neuroreport (1997) 0.92

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J (2000) 0.92

Mode of antinociceptive action of flupirtine in the rat. Br J Pharmacol (1989) 0.91

Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett (1998) 0.90

Carbocyanine dyes stain the sarcoplasmic reticulum of beating heart cells. Exp Cell Res (1980) 0.90

Pharmacological differences between R(-)- and S(+)-ibuprofen. Agents Actions (1989) 0.89

Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res (1998) 0.89

Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration. Antimicrob Agents Chemother (1997) 0.89

Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol (1997) 0.88

Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology (1999) 0.88

Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia. Inflamm Res (2001) 0.88

Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen. Mol Pharmacol (1997) 0.88

Differential effects of dipyrone, ibuprofen, and paracetamol on experimentally induced pain in man. Agents Actions (1992) 0.87

Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen. Br J Pharmacol (1998) 0.87

Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium. Eur J Biochem (2000) 0.87

Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology (1997) 0.87

Parietal cells of the stomach trap salicylates during absorption. Biochem Pharmacol (1977) 0.87

Controversies in COX-2 selective inhibition. J Rheumatol (2002) 0.86

Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column. J Chromatogr (1990) 0.86

Variability of inversion of (R)-flurbiprofen in different species. J Pharm Sci (1992) 0.86

Leishmania major parasites express cyclophilin isoforms with an unusual interaction with calcineurin. Biochem J (1998) 0.86

Autoradiographic methods for the evaluation of ulcerogenic effects of anti-inflammatory drugs. Pharmacol Ther B (1979) 0.85

Adverse drug reactions in patients with gastroenterological diseases: does age increase the risk? Aliment Pharmacol Ther (2001) 0.85

Interleukin-8 is a cyclosporin A binding protein. Experientia (1993) 0.85

Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study. J Neurochem (2000) 0.85

Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief. Eur J Pain (2011) 0.85

Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience (2000) 0.85

Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly. Eur J Pharmacol (1986) 0.84

Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs. Arch Toxicol (1987) 0.84

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J (2001) 0.84

Cyclophilin-A is a zinc-dependent DNA binding protein in macrophages. FEBS Lett (1995) 0.84

Stereoselectivity of biliary excretion of 2-arylpropionates in rats. Chirality (1993) 0.84

Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handb Exp Pharmacol (2007) 0.84

Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects. Br J Clin Pharmacol (1995) 0.84

Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body. Exp Eye Res (2001) 0.83

Autoradiographic and biochemical observations on the distribution of non-steroid anti-inflammatory drugs. Arch Int Pharmacodyn Ther (1981) 0.83

Rapid onset of hematotoxic effects after interferon alpha in hepatitis C. J Hepatol (2000) 0.83

[Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migräne- und Kopfschmerz-Gesellschaft]. Schmerz (2000) 0.83

A new reliable chemiluminescence immunoassay (CLIA) for prostaglandin E2 using enhanced luminol as substrate. Prostaglandins (1996) 0.82

Genetics of the FANCA gene in familial pancreatic cancer. J Med Genet (2004) 0.82

An in vitro system for measuring endothelial permeability under hydrostatic pressure. Exp Cell Res (1983) 0.82

Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate. Br J Clin Pharmacol (2001) 0.82

Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers. Clin Pharmacol Ther (1996) 0.81

Inhibition of prostaglandin synthesis in vivo by nonsteroid anti-inflammatory drugs: evidence for the importance of pharmacokinetics. Agents Actions (1976) 0.81

Host-cell cyclophilin is important for the intracellular replication of Leishmania major. Mol Microbiol (1997) 0.81

Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages. Pharm Res (2001) 0.81

Distribution of extracellular matrix proteins in indomethacin-induced lesions in the rat stomach. Scand J Gastroenterol (1995) 0.81

R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem Biophys Res Commun (2001) 0.81